NEUROCRINE BIOSCIENCES INC (NBIX) Other Assets, Current USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Neurocrine Biosciences Inc quarterly Other Assets, Current history and growth rate from 2010 to 2024.
  • Neurocrine Biosciences Inc Other Assets, Current for the quarter ending March 31, 2024 was $101 M, a 11.2% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $101 M -$12.7 M -11.2% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $97.8 M +$18.7 M +23.6% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $108 M +$40.3 M +59.4% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $101 M +$37.9 M +60.4% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $113 M +$52.4 M +86.2% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $79.1 M +$33.6 M +73.8% Dec 31, 2022 10-K 2024-02-09
Q3 2022 $67.9 M +$17.4 M +34.5% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $62.7 M +$24.3 M +63.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $60.8 M +$27 M +79.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $45.5 M +$15.4 M +51.2% Dec 31, 2021 10-K 2023-02-09
Q3 2021 $50.5 M +$15.8 M +45.5% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $38.4 M +$10.9 M +39.6% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $33.8 M +$7.1 M +26.6% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $30.1 M +$13.5 M +81.3% Dec 31, 2020 10-K 2022-02-11
Q3 2020 $34.7 M +$11.7 M +51.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $27.5 M +$6.05 M +28.2% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 $26.7 M +$2.55 M +10.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $16.6 M -$1.99 M -10.7% Dec 31, 2019 10-K 2021-02-05
Q3 2019 $23 M +$4.05 M +21.5% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $21.5 M +$5.16 M +31.7% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $24.2 M +$15.5 M +180% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $18.6 M +$11.8 M +172% Dec 31, 2018 10-K 2020-02-07
Q3 2018 $18.9 M +$11.5 M +155% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $16.3 M +$10.8 M +195% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $8.61 M +$4.74 M +123% Mar 31, 2018 10-Q 2018-04-30
Q4 2017 $6.84 M +$3.75 M +121% Dec 31, 2017 10-K 2019-02-08
Q3 2017 $7.41 M +$2.56 M +52.8% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 $5.53 M +$961 K +21% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $3.87 M -$506 K -11.6% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $3.09 M -$1.79 M -36.7% Dec 31, 2016 10-K 2018-02-13
Q3 2016 $4.85 M -$1.09 M -18.4% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $4.57 M -$128 K -2.73% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $4.38 M -$539 K -11% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $4.88 M +$489 K +11.1% Dec 31, 2015 10-K 2017-02-14
Q3 2015 $5.94 M +$1.75 M +41.6% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $4.7 M Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $4.92 M Mar 31, 2015 10-Q 2015-04-30
Q4 2014 $4.39 M +$1.67 M +61.4% Dec 31, 2014 10-K 2016-02-11
Q3 2014 $4.19 M +$1.96 M +87.9% Sep 30, 2014 10-Q 2014-11-04
Q4 2013 $2.72 M +$561 K +25.9% Dec 31, 2013 10-K 2015-02-09
Q3 2013 $2.23 M -$456 K -17% Sep 30, 2013 10-Q 2013-10-29
Q2 2013 $2.12 M -$60 K -2.75% Jun 30, 2013 10-Q 2013-07-26
Q1 2013 $2.15 M +$74 K +3.56% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 $2.16 M +$692 K +47.1% Dec 31, 2012 10-K 2014-02-11
Q3 2012 $2.69 M +$590 K +28.1% Sep 30, 2012 10-Q 2012-10-31
Q2 2012 $2.18 M +$213 K +10.8% Jun 30, 2012 10-Q 2012-07-31
Q1 2012 $2.08 M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 $1.47 M -$246 K -14.3% Dec 31, 2011 10-K 2013-02-08
Q3 2011 $2.1 M Sep 30, 2011 10-Q 2011-10-31
Q2 2011 $1.97 M Jun 30, 2011 10-Q 2011-07-29
Q4 2010 $1.72 M Dec 31, 2010 10-K 2012-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.